ACR 2020 Debate: JAK Inhibitors vs Biologics After Methotrexate Failure in RA
Experts at the ACR Convergence conference discussed the use of Janus kinase inhibitors before/after biologics following methotrexate treatment failure in RA.
All articles by Meghna Rao
Hydroxychloroquine May Not Be Associated With Preventive Effect Against SARS-CoV-2 Infection in Rheumatic Diseases
Researchers investigated the risk for SARS-CoV-2 infection in patients with rheumatic disease receiving vs not receiving hydroxychloroquine.
![When communicating with patients, it is essential to provide them with key information about their drug regimen, including what the drug is, why they need it, when and how to take it, and for how long they need to take it. [6] They should also be educated about the fluctuating nature of RA, the consequences of nonadherence, and the potential adverse effects associated with their treatment so that they know what to expect and when to call for instruction, reducing the risk of them altering their regimen. [6,10] Because patients of lower socioeconomic status and ethnic minorities are at especially high risk of nonadherence, the RESPECT model of communicating, which has received recognition for improving cultural competence and overall rapport, might be especially beneficial in the RA setting. RESPECT comprises seven core elements: Respect (show), Explain (provide), Support (provide), Power (share), Empathy (show), Concerns (address), and Trust (build). [11]](https://1fxghyessyy2gaob23ygwzph-wpengine.netdna-ssl.com/wp-content/uploads/sites/18/2019/01/5doctorchartcomputerts541_1041336-544x306.jpg)
Rheumatologists Face Challenges in Identifying High-Quality COVID-19 Literature
Study authors highlighted the challenges associated with the identification of published COVID-19 literature and suggested resources for rheumatologists and their patients.
Perceptions, Practices in RA-ILD Differ Between Rheumatologists and Pulmonologists
There are significant differences in perceptions of prevalence, risk factors, and the management of RA-associated interstitial lung disease between rheumatologists and pulmonologists.
ACR Updates COVID-19 Guidance for the Management of Adult Patients With Rheumatic Diseases
The American College of Rheumatology updated its COVID-19 guidance for the management of adult patients with rheumatic diseases.
Iloprost May Be Useful in the Treatment of COVID-19 Vasculopathy
Authors of this report assessed the role of iloprost in the management of COVID-19-related vasculopathy.
American College of Rheumatology Releases Position Statements for Telemedicine Use
The American College of Rheumatology has issued a set of position statements for the use of telemedicine in the management of patients with rheumatic diseases.
The Autoimmune COVID-19 Project: A Patient-Centered Initiative
Study leads Shilpa Venkatachalam, PhD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.
How Is COVID-19 Affecting the Health of Rheumatologists?
In this episode, we discuss the effect of the COVID-19 pandemic on the health of rheumatologists and how this may have an impact on delivering patient care.
Drug Reaction With Eosinophilia and Systemic Symptoms Linked to High Fatality Lung Disease in JIA
Drug reaction with eosinophilia and systemic symptoms (DReSS) with exposure to interleukin-1 or interleukin-6 inhibition may be linked to high fatality lung disease in systemic juvenile idiopathic arthritis.
-
Loading...
-
Loading...
Next post in Pediatric Rheumatology
